FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Eight Capital

  • Home
  •  | 
  • Tag Archives: "Eight Capital"

48North Enters Into $25 Million Bought Deal Equity Financing

48North Enters Into $25 Million Bought Deal Equity Financing
48North Cannabis Corp. (TSXV:NRTH) (“48North” or the “Company”), is pleased to announce that it has entered into a letter of engagement with Eight Capital, under which Eight Capital has agreed to purchase, as sole bookrunner and lead underwriter, along with a syndicate of underwriters (the “Underwriters”), 18,382,400 units of the Company (the “Units”), on a “bought deal” basis pursuant to a filing of a short form prospectus, subject to all required regulatory approvals, at a price per Unit of $1.36 (the “Issue Price”) for gross proceeds of $25,000,064 (the “Offering”).
Read more

Canopy Rivers Completes Previously Announced Bought Deal and Concurrent Private Placement for Total Gross Proceeds of Approximately $93.5 Million

Canopy Rivers Completes Previously Announced Bought Deal and Concurrent Private Placement for Total Gross Proceeds of Approximately $93.5 Million
Canopy Rivers Inc. (TSXV:RIV) (“Canopy Rivers” or the “Company”) is pleased to announce that it has closed its previously announced bought deal financing (the “Bought Deal”) of subordinated voting shares of the Company (the “Subordinated Voting Shares”) with a syndicate of underwriters (the “Underwriters”) led by CIBC Capital Markets (“CIBC”) and Eight Capital (together with CIBC, the “Joint Bookrunners”). The Bought Deal consisted of an aggregate of 13,225,000 Subordinated Voting Shares, which reflects the exercise in full of the Underwriters’ over-allotment option, at a price of $4.80 per Subordinated Voting Share (the “Issue Price”) for gross proceeds of approximately $63.5 million.
Read more

MedMen Enters Into CAD$75 Million Bought Deal Equity Financing

MedMen Enters Into CAD$75 Million Bought Deal Equity Financing
MedMen Enterprises Inc. (CSE:MMEN)(OTCQB: MMNFF) (FSE: A2JM6N) (“MedMen” or the “Company”), is pleased to announce that it has entered into a letter of engagement with Eight Capital, under which Eight Capital has agreed to purchase, as co-lead underwriter and joint bookrunner, along with Cormark Securities Inc. as co-lead underwriter and joint bookrunner, and a syndicate of underwriters (together with Eight Capital and Cormark Securities Inc., the “Underwriters”), 13,636,364 units of the Company (the “Units”), on a “bought deal” basis pursuant to a filing of a short form prospectus, subject to all required regulatory approvals, at a price per Unit of CAD$5.50 (the “Issue Price”) for gross proceeds of CAD$75,000,002 (the “Offering”). 
Read more